Projects per year
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 2 Similar Profiles
Cells
Chemical Compounds
Apoptosis
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Nicotine
Medicine & Life Sciences
terbinafine
Medicine & Life Sciences
Nicotinic Receptors
Medicine & Life Sciences
Hepatocellular Carcinoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2019
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)
8/1/18 → 7/31/19
Project: b - Ministry of Science and Technology
組織胺甲基化轉換酵素參與國人乳癌細胞對賀癌平(HerceptinR)形成抗藥性之探討(3/3)
8/1/18 → 7/31/19
Project: b - Ministry of Science and Technology
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估－α9尼古丁受體蛋白多形性變異致癌作用之機制探討(2/3)(相對補助)
8/1/18 → 7/31/19
Project: f - Other (Funded by Government)
組織胺甲基化轉換酵素參與國人乳癌細胞對賀癌平(HerceptinR)形成抗藥性之探討(2/3)
8/1/17 → 7/31/18
Project: b - Ministry of Science and Technology
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體蛋白多形性變異致癌作用之機制探討(1/3)
8/1/17 → 7/31/18
Project: b - Ministry of Science and Technology
Research Output 1992 2019
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint
Lee, W-H., Chen, L-C., Lee, C-J., Huang, C-C., Ho, Y-S., Yang, P-S., Ho, C-T., Chang, H-L., Lin, I-H., Chang, H-W., Liu, Y-R., Wu, C-H. & Tu, S-H., Feb 1 2019, In : International Journal of Cancer. 144, 3, p. 615-630 16 p.Research output: Contribution to journal › Article
DNA Primase
G2 Phase Cell Cycle Checkpoints
Estrogens
Breast Neoplasms
Peptides
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. Y., Chen, M., Chen, L. C., Ho, Y. S., Ho, H. O., Lin, S. Y., Chuang, K. H. & Sheu, M. T., Nov 1 2018, In : Drug Delivery. 25, 1, p. 1066-1079 14 p.Research output: Contribution to journal › Article
docetaxel
Bispecific Antibodies
Lecithins
Drug Delivery Systems
Neoplasms
Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (LsbMDDs) for improving the therapeutic efficacy and reducing systemic toxicity
Su, C. Y., Liu, J. J., Ho, Y. S., Huang, Y. Y., Chang, V. H. S., Liu, D. Z., Chen, L. C., Ho, H. O. & Sheu, M. T., Feb 1 2018, In : European Journal of Pharmaceutics and Biopharmaceutics. 123, p. 9-19 11 p.Research output: Contribution to journal › Article
docetaxel
Lecithins
Drug Delivery Systems
Therapeutics
Neoplasms
HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1
Bamodu, O. A., Kuo, K. T., Yuan, L. P., Cheng, W. H., Lee, W. H., Ho, Y. S., Chao, T. Y. & Yeh, C. T., Jan 1 2018, (Accepted/In press) In : Experimental Cell Research.Research output: Contribution to journal › Article
Myeloid Progenitor Cells
Histone Deacetylases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Pharmaceutical Preparations
Neoplastic Stem Cells
Long-term exposure to extremely low-dose of nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway
Fararjeh, A-FS., Tu, S-H., Chen, L-C., Cheng, T-C., Liu, Y-R., Chang, H-L., Chang, H-W., Huang, C-C., Wang, H-CR., Hwang-Verslues, W. W., Wu, C-H. & Ho, Y-S., 2018, In : Environmental Toxicology.Research output: Contribution to journal › Article
Nicotinic Receptors
Nicotine
Tobacco Smoke Pollution
Smoke
smoke
Press / Media
US Patent Issued to TAIPEI MEDICAL UNIVERSITY, NATIONAL HEALTH RESEARCH INSTITUTE on Dec. 1 for "Method for the diagnosis of the presence of an ovarian cancer" (Taiwanese Inventors)
Yi-Yuan Yang, Jen-Hung Huang, Yuan-Soon Ho, Ching-Kuo Lee & Yu-Ching Lee
12/2/15
2 items of media coverage
Press/Media: Press / Media